Clas.10x50 DPSI - Jumelles OLYMPUS - Notice d'utilisation et mode d'emploi gratuit
Retrouvez gratuitement la notice de l'appareil Clas.10x50 DPSI OLYMPUS au format PDF.
| Caractéristiques | Détails |
|---|---|
| Type de jumelles | Jumelles d'observation |
| Grossissement | 10x |
| Diamètre de l'objectif | 50 mm |
| Champ de vision à 1000 m | 114 m |
| Distance minimale de mise au point | 7 m |
| Poids | 900 g |
| Type de prisme | Porro |
| Revêtement | Antireflet et étanche |
| Utilisation recommandée | Observation de la nature, événements sportifs, voyages |
| Entretien | Nettoyer avec un chiffon doux, éviter les produits abrasifs |
| Sécurité | Ne pas exposer à des températures extrêmes, éviter les chocs |
| Garantie | 2 ans |
FOIRE AUX QUESTIONS - Clas.10x50 DPSI OLYMPUS
Questions des utilisateurs sur Clas.10x50 DPSI OLYMPUS
0 question sur cet appareil. Repondez a celles que vous connaissez ou posez la votre.
Poser une nouvelle question sur cet appareil
Téléchargez la notice de votre Jumelles au format PDF gratuitement ! Retrouvez votre notice Clas.10x50 DPSI - OLYMPUS et reprennez votre appareil électronique en main. Sur cette page sont publiés tous les documents nécessaires à l'utilisation de votre appareil Clas.10x50 DPSI de la marque OLYMPUS.
MODE D'EMPLOI Clas.10x50 DPSI OLYMPUS
OLYMPUS
Binoculars
| INTSTRUCTIONS | IN N STRU |
| AUXIANT | AUXIANT |
| AVXO K P OZDI | AUXIANZERQUEN |
| AVXO L P OZDI | AVXO L AUXIANT |
| BETTANING | BETTANZERLEND |
| BETTANING/SEVERING | BETTICRUSTIC |
| AHMED | BETTRICRUSTIC |
| AUXIANT | BETTRICRUSTIC |
| AUXIANT/QUET | BETTIPYPRAS |
| AMOX | AMOX |
| AMOX | NAVOLICA |
| AMOX | AMOX |
| HAZARALTAL UNTATATO | UPOTYTOV 2A YPOBETTE |
| BETTIOZON | BETTIOZON |
| BETTIOZON | BETTIPYPRUS |
Y8802121
| 1 | ||
| 2 | 3 | |
| 4 | 6 | |
| 7 |
Before using your biocassette, read this text carefully to ensure correct size. After reading the text, please use a small, single
| Question | Explanation |
| 1. What is the best way to use the radio with voiceovers? | |
| 2. Do you think the radio is a suitable tool for a student to prepare for an interview or presentation? | |
| 3. What are the advantages of using this technology? | |
| 4. What are the disadvantages of using this technology? | |
| 5. What are the main problems with using this technology? | |
| 6. What are the main difficulties in using this technology? | |
| 7. What are the main difficulties in using this technology? | |
| 8. What are the main difficulties in using this technology? | |
| 9. What are the main difficulties in using this technology? | |
| 10. What are the main difficulties in using this technology? | |
| 11. What are the main difficulties in using this technology? | |
| 12. What are the main difficulties in using this technology? | |
| 13. What are the main difficulties in using this technology? | |
| 14. What are the main difficulties in using this technology? | |
| 15. What are the main difficulties in using this technology? | |
| 16. What are the main difficulties in using this technology? | |
| 17. What are the main difficulties in using this technology? | |
| 18. What are the main difficulties in using this technology? | |
| 19. What are the main difficulties in using this technology? | |
| 20. What are the main difficulties in using this technology? | |
| 21. What are the main difficulties in using this technology? | |
| 22. What are the main difficulties in using this technology? | |
| 23. What are the main difficulties in using this technology? | |
| 24. What are the main difficulties in using this technology? | |
| 25. What are the main difficulties in using this technology? | |
| 26. What are the main difficulties in using this technology? | |
| 27. What are the main difficulties in using this technology? | |
| 28. What are the main difficulties in using this technology? | |
| 29. What are the main difficulties in using this technology? | |
| 30. What are the main difficulties in using this technology? | |
| 31. What are the main difficulties in using this technology? | |
| 32. What are the main difficulties in using this technology? | |
| 33. What are the main difficulties in using this technology? | |
| 34. What are the main difficulties in using this technology? | |
| 35. What are the main difficulties in using this technology? | |
| 36. What are the main difficulties in using this technology? | |
| 37. What are the main difficulties in using this technology? | |
| 38. What are the main difficulties in using this technology? | |
| 39. What are the main difficulties in using this technology? | |
| 40. What are the main difficulties in using this technology? | |
| 41. What are the main difficulties in using this technology? | |
| 42. What are the main difficulties in using this technology? | |
| 43. What are the main difficulties in using this technology? | |
| 44. What are the main difficulties in using this technology? | |
| 45. What are the main difficulties in using this technology? | |
| 46. What are the main difficulties in using this technology? | |
| 47. What are the main difficulties in using this technology? | |
| 48. What are the main difficulties in using this technology? | |
| 49. What are the main difficulties in using this technology? | |
| 50. What are the main difficulties in using this technology? | |
| 51. What are the main difficulties in using this technology? | |
| 52. What are the main difficulties in using this technology? | |
| 53. What are the main difficulties in using this technology? | |
| 54. What are the main difficulties in using this technology? | |
| 55. What are the main difficulties in using this technology? | |
| 56. What are the main difficulties in using this technology? | |
| 57. What are the main difficulties in using this technology? | |
| 58. What are the main difficulties in using this technology? | |
| 59. What are the main difficulties in using this technology? | |
| 60. What are the main difficulties in using this technology? | |
| 61. What are the main difficulties in using this technology? | |
| 62. What are the main difficulties in using this technology? | |
| 63. What are the main difficulties in using this technology? | |
| 64. What are the main difficulties in using this technology? | |
| 65. What are the main difficulties in using this technology? | |
| 66. What are the main difficulties in using this technology? | |
| 67. What are the main difficulties in using this technology? | |
| 68. What are the main difficulties in using this technology? | |
| 69. What are the main difficulties in using this technology? | |
| 70. What are the main difficulties in using this technology? | |
| 71. What are the main difficulties in using this technology? | |
| 72. What are the main difficulties in using this technology? | |
| 73. What are the main difficulties in using this technology? | |
| 74. What are the main difficulties in using this technology? | |
| 75. What are the main difficulties in using this technology? | |
| 76. What are the main difficulties in using this technology? | |
| 77. What are the main difficulties in using this technology? | |
| 78. What are the main difficulties in using this technology? | |
| 79. What are the main difficulties in using this technology? | |
| 80. What are the main difficulties in using this technology? | |
| 81. What are the main difficulties in using this technology? | |
| 82. What are the main difficulties in using this technology? | |
| 83. What are the main difficulties in using this technology? | |
| 84. What are the main difficulties in using this technology? | |
| 85. What are the main difficulties in using this technology? | |
| 86. What are the main difficulties in using this technology? | |
| 87. What are the main difficulties in using this technology? | |
| 88. What are the main difficulties in using this technology? | |
| 89. What are the main difficulties in using this technology? | |
| 90. What are the main difficulties in using this technology? | |
| 91. What are the main difficulties in using this technology? | |
| 92. What are the main difficulties in using this technology? | |
| 93. What are the main difficulties in using this technology? | |
| 94. What are the main difficulties in using this technology? | |
| 95. What are the main difficulties in using this technology? | |
| 96. What are the main difficulties in using this technology? | |
| 97. What are the main difficulties in using this technology? | |
| 98. What are the main difficulties in using this technology? | |
| 99. What are the main difficulties in using this technology? | |
| 100. What are the main difficulties in using this technology? | |
| • The study was conducted in collaboration with the European Union, and the research was funded by the European Union. |
| • The authors do not have financial interests in the research; they do not have personal or financial interests in the research; neither do they have financial interests in other companies that are involved in the research. |
| • The authors do not have financial interests in other companies that are involved in the design of the study. |
| • The authors do not have financial interests in other companies that are involved in the analysis of the results. |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results. |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results. |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results. |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results. |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that are involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results. |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do not have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies thatARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results |
| • The authors do NOT have financial interests in other companies that ARE involved in the interpretation of the results. |
| 1. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 2. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 3. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 4. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 5. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 6. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 7. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 8. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 9. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 10. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 11. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 12. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 13. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 14. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 15. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 16. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 17. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 18. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 19. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 20. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 21. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 22. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 23. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 24. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 25. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 26. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 27. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 28. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 29. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 30. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 31. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 32. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 33. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 34. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 35. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 36. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 37. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 38. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 39. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 40. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 41. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 42. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 43. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 44. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 45. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 46. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 47. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 48. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 49. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 50. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 51. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 52. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 53. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 54. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 55. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 56. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 57. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 58. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 59. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 60. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 61. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 62. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 63. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 64. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 65. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 66. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 67. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 68. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 69. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 70. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 71. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 72. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 73. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 74. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 75. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 76. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 77. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 78. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 79. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 80. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 81. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 82. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 83. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 84. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 85. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 86. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 87. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 88. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 89. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 90. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 91. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 92. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 93. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 94. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 95. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 96. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 97. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 98. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 99. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 100. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 101. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 102. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 103. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 104. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 105. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 106. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 107. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 108. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 109. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 110. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 111. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 112. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 113. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 114. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 115. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 116. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 117. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 118. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 119. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 120. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 121. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 122. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 123. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 124. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 125. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 126. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 127. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 128. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 129. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 130. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 131. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 132. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 133. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 134. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 135. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 136. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 137. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 138. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 139. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 140. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 141. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 142. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 143. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 144. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 145. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 146. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 147. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 148. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 149. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 150. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 151. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 152. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 153. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 154. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 155. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 156. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 157. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 158. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 159. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 160. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 161. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 162. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 163. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 164. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 165. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 166. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 167. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 168. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 169. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 170. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 171. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 172. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 173. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 174. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 175. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 176. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 177. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 178. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 179. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 180. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 181. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 182. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 183. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 184. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 185. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 186. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 187. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 188. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 189. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 190. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 191. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 192. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 193. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 194. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 195. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 196. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 197. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 198. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 199. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 200. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 201. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 202. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 203. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 204. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 205. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 206. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 207. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 208. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 209. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 210. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 211. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 212. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 213. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 214. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 215. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 216. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 217. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 218. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 219. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 220. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 221. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 222. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 223. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 224. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 225. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 226. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 227. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 228. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 229. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 230. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 231. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 232. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 233. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 234. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 235. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 236. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 237. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 238. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 239. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 240. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 241. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 242. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 243. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 244. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 245. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 246. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 247. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 248. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 249. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 250. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 251. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 252. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 253. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 254. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 255. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 256. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 257. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 258. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 259. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 260. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 261. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 262. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 263. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 264. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 265. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 266. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 267. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 268. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 269. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 270. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 271. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 272. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 273. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 274. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 275. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 276. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 277. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 278. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 279. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 280. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 281. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 282. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 283. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 284. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 285. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 286. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 287. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 288. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 289. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 290. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 291. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 292. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 293. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 294. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 295. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 296. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 297. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 298. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 299. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 300. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 301. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 302. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 303. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 304. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 305. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 306. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 307. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 308. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 309. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 310. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 311. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 312. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 313. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 314. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 315. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 316. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 317. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 318. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 319. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 320. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 321. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 322. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 323. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 324. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 325. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 326. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 327. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 328. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 329. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 330. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 331. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 332. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 333. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 334. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 335. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 336. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 337. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 338. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 339. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 340. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 341. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 342. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 343. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 344. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 345. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 346. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 347. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 348. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 349. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 350. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 351. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 352. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 353. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 354. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 355. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 356. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 357. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 358. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 359. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 360. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 361. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 362. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 363. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 364. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 365. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 366. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 367. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 368. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 369. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 370. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 371. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 372. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 373. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 374. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 375. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 376. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 377. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 378. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 379. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 380. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 381. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 382. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 383. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 384. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 385. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 386. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 387. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 388. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 389. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 390. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 391. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 392. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 393. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 394. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 395. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 396. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 397. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 398. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 399. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 400. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 401. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 402. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 403. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 404. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 405. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 406. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 407. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 408. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 409. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 410. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 411. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 412. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 413. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 414. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 415. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 416. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 417. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 418. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 419. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 420. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 421. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 422. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 423. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 424. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 425. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 426. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 427. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 428. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 429. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 430. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 431. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 432. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 433. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 434. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 435. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 436. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 437. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 438. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 439. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 440. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 441. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 442. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 443. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 444. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 445. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 446. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 447. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 448. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 449. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 450. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 451. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 452. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 453. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 454. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 455. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 456. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 457. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 458. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 459. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 460. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 461. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 462. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 463. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 464. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 465. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 466. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 467. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 468. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 469. The study aims to evaluate the impact of the use of a health care provider on the quality of life of patients with cancer and their families. |
| 470. The study aims to evaluate the impact if |
| 1. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 2. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 3. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 4. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 5. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 6. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 7. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 8. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 9. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 10. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 11. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 12. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 13. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 14. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 15. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 16. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 17. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 18. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 19. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 20. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 21. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 22. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 23. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 24. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 25. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 26. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 27. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 28. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 29. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 30. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 31. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 32. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 33. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 34. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 35. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 36. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 37. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 38. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 39. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 40. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 41. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 42. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 43. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 44. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 45. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 46. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 47. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 48. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 49. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 50. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 51. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 52. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 53. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 54. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 55. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 56. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 57. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 58. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 59. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 60. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 61. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 62. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 63. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 64. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 65. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 66. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 67. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 68. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 69. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 70. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 71. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 72. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 73. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 74. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 75. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 76. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 77. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 78. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 79. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 80. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 81. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 82. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 83. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 84. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 85. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 86. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 87. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 88. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 89. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 90. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 91. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 92. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 93. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 94. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 95. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 96. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 97. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 98. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 99. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 100. | A person who has been diagnosed with cancer and is currently on treatment for cancer. |
| 1. | Low risk for developing asthma and lung disease, but high risk for developing chronic lung disease |
| 2. | High risk for developing asthma and lung disease, but low risk for developing chronic lung disease |
| 3. | No risk for developing asthma and lung disease |
| 4. | No risk for developing chronic lung disease |
| 5. | No risk for developing chronic lung disease |
| 6. | No risk for developing asthma and lung disease |
| 7. | No risk for developing asthma and lung disease |
| 8. | No risk for developing asthma and lung disease |
| 9. | No risk for developing asthma and lung disease |
| 10. | No risk for developing asthma and lung disease |
| 11. | No risk for developing asthma and lung disease |
| 12. | No risk for developing asthma and lung disease |
| 13. | No risk for developing asthma and lung disease |
| 14. | No risk for developing asthma and lung disease |
| 15. | No risk for developing asthma and lung disease |
| 16. | No risk for developing asthma and lung disease |
| 17. | No risk for developing asthma and lung disease |
| 18. | No risk for developing asthma and lung disease |
| 19. | No risk for developing asthma and lung disease |
| 20. | No risk for developing asthma and lung disease |
| 21. | No risk for developing asthma and lung disease |
| 22. | No risk for developing asthma and lung disease |
| 23. | No risk for developing asthma and lung disease |
| 24. | No risk for developing asthma and lung disease |
| 25. | No risk for developing asthma and lung disease |
| 26. | No risk for developing asthma and lung disease |
| 27. | No risk for developing asthma and lung disease |
| 28. | No risk for developing asthma and lung disease |
| 29. | No risk for developing asthma and lung disease |
| 30. | No risk for developing asthma and lung disease |
| 31. | No risk for developing asthma and lung disease |
| 32. | No risk for developing asthma and lung disease |
| 33. | No risk for developing asthma and lung disease |
| 34. | No risk for developing asthma and lung disease |
| 35. | No risk for developing asthma and lung disease |
| 36. | No risk for developing asthma and lung disease |
| 37. | No risk for developing asthma and lung disease |
| 38. | No risk for developing asthma and lung disease |
| 39. | No risk for developing asthma and lung disease |
| 40. | No risk for developing asthma and lung disease |
| 41. | No risk for developing asthma and lung disease |
| 42. | No risk for developing asthma and lung disease |
| 43. | No risk for developing asthma and lung disease |
| 44. | No risk for developing asthma and lung disease |
| 45. | No risk for developing asthma and lung disease |
| 46. | No risk for developing asthma and lung disease |
| 47. | No risk for developing asthma and lung disease |
| 48. | No risk for developing asthma and lung disease |
| 49. | No risk for developing asthma and lung disease |
| 50. | No risk for developing asthma and lung disease |
| 51. | No risk for developing asthma and lung disease |
| 52. | No risk for developing asthma and lung disease |
| 53. | No risk for developing asthma and lung disease |
| 54. | No risk for developing asthma and lung disease |
| 55. | No risk for developing asthma and lung disease |
| 56. | No risk for developing asthma and lung disease |
| 57. | No risk for developing asthma and lung disease |
| 58. | No risk for developing asthma and lung disease |
| 59. | No risk for developing asthma and lung disease |
| 60. | No risk for developing asthma and lung disease |
| 61. | No risk for developing asthma and lung disease |
| 62. | No risk for developing asthma and lung disease |
| 63. | No risk for developing asthma and lung disease |
| 64. | No risk for developing asthma and lung disease |
| 65. | No risk for developing asthma and lung disease |
| 66. | No risk for developing asthma and lung disease |
| 67. | No risk for developing asthma and lung disease |
| 68. | No risk for developing asthma and lung disease |
| 69. | No risk for developing asthma and lung disease |
| 70. | No risk for developing asthma and lung disease |
| 71. | No risk for developing asthma and lung disease |
| 72. | No risk for developing asthma and lung disease |
| 73. | No risk for developing asthma and lung disease |
| 74. | No risk for developing asthma and lung disease |
| 75. | No risk for developing asthma and lung disease |
| 76. | No risk for developing asthma and lung disease |
| 77. | No risk for developing asthma and lung disease |
| 78. | No risk for developing asthma and lung disease |
| 79. | No risk for developing asthma and lung disease |
| 80. | No risk for developing asthma and lung disease |
| 81. | No risk for developing asthma and lung disease |
| 82. | No risk for developing asthma and lung disease |
| 83. | No risk for developing asthma and lung disease |
| 84. | No risk for developing asthma and lung disease |
| 85. | No risk for developing asthma and lung disease |
| 86. | No risk for developing asthma and lung disease |
| 87. | No risk for developing asthma and lung disease |
| 88. | No risk for developing asthma and lung disease |
| 89. | No risk for developing asthma and lung disease |
| 90. | No risk for developing asthma and lung disease |
| 91. | No risk for developing asthma and lung disease |
| 92. | No risk for developing asthma and lung disease |
| 93. | No risk for developing asthma and lung disease |
| 94. | No risk for developing asthma and lung disease |
| 95. | No risk for developing asthma and lung disease |
| 96. | No risk for developing asthma and lung disease |
| 97. | No risk for developing asthma and lung disease |
| 98. | No risk for developing asthma and lung disease |
| 99. | No risk for developing asthma and lung disease |
| 100. | No risk for developing asthma and lung disease |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or mortality in people with cancer. |
| • The main activities: develop a new cancer screening system, develop a new cancer screening technology, and develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or mortality in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or mortality in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or mortality in people with cancer. |
| •The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or mortality in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of Life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer Screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancers. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and reduce the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and decrease the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and decrease the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and decrease the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and increase the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and increase the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and increase the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology, develop a new cancer screening program to reduce cancer deaths. In addition, develop a new cancer screening technology for people with cancer. |
| • The main objectives: improve the quality of life and decrease the risk of death, disability, or survival rate in people with cancer. |
| • The main activities: develop a new cancer screening technology; develop a new cancer screening program; and develop a new cancer screening technology for people with cancer. |
| Question | Explanation |
| 1. What is the best way to use the Internet for your health care provider? | The best way to use the Internet is to use the Internet to search for information about a particular health care provider. |
| 2. How do you use the Internet to make your health care provider's appointments? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 3. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 4. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 5. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 6. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 7. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 8. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 9. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 10. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 11. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 12. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 13. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 14. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 15. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 16. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 17. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 18. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 19. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 20. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 21. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 22. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 23. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 24. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 25. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 26. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 27. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 28. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 29. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 30. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 31. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 32. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 33. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 34. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 35. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 36. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 37. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 38. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 39. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 40. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 41. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 42. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 43. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 44. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 45. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 46. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 47. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 48. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 49. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 50. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 51. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 52. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 53. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 54. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 55. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 56. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 57. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 58. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 59. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 60. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 61. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 62. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 63. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 64. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 65. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 66. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 67. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 68. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 69. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| 70. How do you use the Internet to make your health care provider's appointment booking? | The best way to use the Internet is to use the Internet to search for appointments and contact the health care provider. |
| Question | Explanation |
| 1. The patient has a history of alcohol abuse and/or is currently on treatment for alcohol problems. | |
| 2. The patient has a history of alcohol abuse and/or is currently on treatment for alcohol problems. | |
| 3. Alcohol use: | |
| A. The patient has been drinking alcohol in the past 12 months. | |
| B. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| C. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| D. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| E. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| F. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| G. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| H. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| I. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| J. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| K. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| L. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| M. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| N. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| O. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| P. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| Q. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| R. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| S. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| T. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| U. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| V. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| W. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| X. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| Y. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| Z. The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| a) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| b) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| c) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| d) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| e) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| f) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| g) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| h) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| i) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| j) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| k) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| l) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| m) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| n) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| o) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| p) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| q) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| r) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| s) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| t) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| u) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| v) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| w) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| x) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| y) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| z) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| #) The patient has been drinking alcohol in the past 12 months, but has not been able to stop using alcohol. | |
| Question | Explanation |
| 1. Is it possible to make a good choice between the two options? | The answer is: yes, but not no. The answer is: no, but yes. |
| 2. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 3. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 4. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 5. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 6. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 7. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 8. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 9. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 10. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 11. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 12. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 13. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 14. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 15. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 16. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 17. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 18. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 19. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 20. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 21. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 22. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 23. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 24. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 25. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 26. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 27. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 28. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 29. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 30. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 31. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 32. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 33. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 34. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 35. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 36. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 37. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 38. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 39. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 40. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 41. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 42. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 43. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 44. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 45. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 46. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 47. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 48. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 49. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 50. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 51. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 52. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 53. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 54. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 55. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 56. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 57. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 58. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 59. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 60. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 61. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 62. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 63. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 64. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 65. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 66. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 67. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 68. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 69. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 70. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 71. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 72. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 73. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 74. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 75. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 76. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 77. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 78. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 79. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 80. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 81. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 82. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 83. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 84. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 85. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 86. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 87. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 88. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 89. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 90. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 91. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 92. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 93. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 94. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 95. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 96. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 97. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 98. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 99. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| 100. Is it possible to make a good choice between the two options? | The answer is: no, but yes. |
| A. Assumptions | |
| 1. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in time or location. | |
| 2. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 3. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 4. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 5. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 6. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 7. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 8. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 9. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 10. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 11. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 12. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 13. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 14. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 15. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 16. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 17. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 18. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 19. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 20. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 21. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 22. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 23. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 24. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 25. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 26. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 27. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 28. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 29. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 30. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 31. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 32. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 33. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 34. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 35. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 36. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 37. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 38. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 39. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 40. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 41. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 42. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 43. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 44. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 45. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 46. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 47. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 48. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 49. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 50. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 51. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 52. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 53. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 54. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 55. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 56. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 57. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 58. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 59. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 60. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 61. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 62. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 63. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 64. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 65. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 66. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 67. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 68. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 69. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 70. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 71. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 72. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 73. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 74. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 75. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 76. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 77. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 78. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 79. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 80. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 81. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 82. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 83. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 84. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 85. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 86. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 87. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 88. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 89. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 90. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 91. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 92. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 93. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 94. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 95. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 96. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 97. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 98. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 99. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. | |
| 100. The assumption that the underlying process is a stationary process, i.e., that it is not subject to change in location or location. |
| 1. | The purpose of the study was to evaluate the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 2. | The aim of the study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 3. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 4. | The aim of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 5. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 6. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 7. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 8. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 9. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 10. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 11. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 12. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 13. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 14. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 15. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 16. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 17. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 18. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 19. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 20. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 21. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 22. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 23. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 24. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 25. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 26. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 27. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 28. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 29. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 30. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 31. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 32. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 33. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 34. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 35. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 36. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 37. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 38. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 39. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 40. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 41. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 42. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 43. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 44. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 45. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 46. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 47. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 48. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 49. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 50. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 51. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 52. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 53. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 54. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 55. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 56. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 57. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 58. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 59. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 60. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 61. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 62. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 63. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 64. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 65. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 66. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 67. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 68. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 69. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 70. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 71. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 72. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 73. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 74. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 75. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 76. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 77. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 78. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 79. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 80. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 81. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 82. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 83. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 84. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 85. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 86. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 87. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 88. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 89. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 90. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 91. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 92. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 93. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 94. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 95. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 96. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 97. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 98. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 99. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 100. | The purpose of this study was to assess the impact of the use of a computer-based tool on the quality of life and physical functioning of older adults in the community. |
| 1. | The purpose of the study was to investigate the relationship between the use of a computer and the amount of time spent in computer use. |
| 2. | The aim of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 3. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 4. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 5. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 6. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 7. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 8. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 9. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 10. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 11. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 12. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 13. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 14. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 15. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 16. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 17. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 18. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 19. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 20. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 21. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 22. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 23. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 24. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 25. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 26. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 27. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 28. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 29. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 30. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 31. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 32. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 33. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 34. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 35. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 36. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 37. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 38. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 39. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 40. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 41. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 42. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 43. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 44. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 45. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 46. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 47. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 48. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 49. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 50. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 51. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 52. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 53. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 54. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 55. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 56. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 57. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 58. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 59. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 60. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 61. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 62. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 63. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 64. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 65. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 66. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 67. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 68. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 69. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 70. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 71. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 72. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 73. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 74. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 75. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 76. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 77. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 78. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 79. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 80. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 81. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 82. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 83. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 84. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 85. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 86. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 87. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 88. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 89. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 90. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 91. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 92. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 93. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 94. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 95. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 96. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 97. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 98. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 99. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 100. | The purpose of this study was to investigate the relationship between the amount of time spent in computer use and the amount of time spent in other activities. |
| 1. | The main purpose of this study was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 2. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 3. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 4. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 5. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 6. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 7. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 8. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 9. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 10. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 11. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 12. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 13. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 14. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 15. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 16. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 17. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 18. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 19. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 20. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 21. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 22. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 23. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 24. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 25. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 26. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 27. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 28. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 29. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 30. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 31. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 32. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 33. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 34. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 35. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 36. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 37. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 38. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 39. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 40. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 41. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 42. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 43. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 44. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 45. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 46. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 47. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 48. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 49. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 50. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 51. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 52. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 53. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 54. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 55. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 56. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 57. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 58. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 59. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 60. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 61. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 62. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 63. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 64. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 65. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 66. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 67. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 68. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 69. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 70. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 71. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 72. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 73. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 74. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 75. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 76. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 77. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 78. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 79. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 80. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 81. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 82. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 83. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 84. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 85. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 86. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 87. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 88. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 89. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 90. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 91. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 92. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 93. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 94. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 95. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 96. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 97. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 98. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 99. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
| 100. | The main aim was to investigate the relationship between the presence and severity of depression and anxiety in patients with major depression (MMD). |
OLYMPUS
| CONNECTIONS OF INTEREST | CONNECTIONS OF INTEREST |
| CONNECTIONS OF INTEREST AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSES AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSET AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSESSMENTS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSEDASMENTS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASES AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASALES AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASPECTS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSENSISMS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSENISMS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| CONNECTIONS OF INTEREST AND FINANCE AND OTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE | CONNECTIONS OF INTEREST AND FINANCE ANDOTHER ASSETS AND FINANCE AND OTHER ASSETS AND FINANCE |
| Treatment (μg/L) | HEATCRF1 | HEATCRF2 | HEATCRF3 | HEATCRF4 | HEATCRF5 | HEATCRF6 | HEATCRF7 | HEATCRF8 | HEATCRF9 | HEATCRF10 | HEATCRF11 | HEATCRF12 | HEATCRF13 | HEATCRF14 | HEATCRF15 | HEATCRF16 | HEATCRF17 | HEATCRF18 | HEATCRF19 | HEATCRF20 | HEATCRF21 | HEATCRF22 | HEATCRF23 | HEATCRF24 | |
| Age | Median (Range from 0.0001 to 1.000) | ||||||||||||||||||||||||
| Mean (Range from 0.0001 to 1.000) | |||||||||||||||||||||||||
| Regimen | 46 | 126 | 87 | 50 | 126 | 8 | 4 | 50 | 126 | 8 | 50 | 126 | 8 | 4 | 116 | 8 | 4 | 116 | 8 | 50 | 116 | 8 | 50 | 116 | 8 |
| Dose of dexamethasone (μg) | 20 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | |
| Dose of levothyroxine (μg) | 3.5 | 4.2 | 5.3 | 4.3 | 4.3 | 4.3 | 5.6 | 5.3 | 5.3 | 5.3 | 3.5 | 3.5 | 2.4 | 2.4 | 2.1 | 1.5 | 1.8 | 2.5 | 3.5 | 3.5 | 2.9 | 2.1 | 2.6 | 3.5 | |
| Dose of metronidazole (μg) | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | |
| Average dose of metronidazole (μg) | 83.4 | 83.4 | 92.6* | 92.7* | 88.7 | 89.7* | 93.4* | 88.7 | 89.7* | 89.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | 88.7* | |
| Dose of levothyroxine (μg) | 20 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | 50 | 100 | 80 | |
| Dose of metronidazole (μg) | 26 | 10 | 20 | 10 | 10 | 10 | 25 | 25 | 25 | 25 | 10 | 10 | 25 | 25 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | |
| Dose of levothyroxine (μg) | 46 | 8 | 20 | 20 | 10 | 10 | 45 | 45 | 10 | 10 | 10 | 10 | 25 | 25 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 8 | 10 | 11 | |
| Dose of metronidazole (μg) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Dose of metronidazole (μg) | mean (Range from 0.0001 to 1.000) | ||||||||||||||||||||||||
| Time from onset of the acute stage (μg) | |||||||||||||||||||||||||
| Time from onset of the acute stage (μg) | 3 | 4* | 4 | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 3* | 4 | |
| Mean (Range) | 800 | 800 | 700 | 700 | 800 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | |
| Median (Range) | 100 | 100 | 90* | 90* | 100 | 90 | 90 | 90 | 90 | 90 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | |
| Mean (Range) | 800 | 800 | 700 | 700 | 800 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | ||
| Median (Range) | 50 | 50 | 50* | 50* | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | ||
| Parameter | Description | Units |
| % (mean ± SD) | Blood glucose level | mmol/L |
| HbA1c(%) | Serum glucose concentration in mmol/L | mmol/L |
| Glucose concentration in mmol/L | Serum glucose concentration in mmol/L | mmol/L |
| Insulin concentration in μU/mL | Serum insulin concentration in μU/mL | μIU/mL |
| Insulin concentration in μU/mL | Serum insulin concentration in μU/mL | μIU/mL |
| Insulin concentration in nmol/L | Serum insulin concentration in nmol/L | nmol/L |
| Insulin concentration in nmol/L | Serum insulin concentration in nmol/L | nmol/L |
| Insulin concentration in pg/mL | Serum insulin concentration in pg/mL | pg/mL |
| Insulin concentration in pg/mL | Serum insulin concentration in pg/mL | pg/mL |
| Insulin concentration in ng/mL | Serum insulin concentration in ng/mL | ng/mL |
| Insulin concentration in IU/mL | Serum insulin concentration in IU/mL | IU/mL |
| Insulin concentration in U/mL | Serum insulin concentration in U/mL | U/mL |
| Insulin concentration in IU/mL | Serum insulin concentration in IU/mL | IU/mL |
| Insulin concentration in nmol/L | Serum insulin concentration in nmol/L | nmol/L |
| Insulin concentration in nmol/L | Serum insulin concentration in nmol/L | nmol/L |
| Insulin concentration in pg/mL | Serum insulin concentration in pg/mL | pg/mL |
| Insulin concentration in pg/mL | Serum insulin concentration in pg/mL | pg/mL |
| Insulin concentration in IU/mL | Serum insulin concentration in IU/mL | IU/mL |
| Insulin concentration in IU/mL | Serum insulin concentration in IU/mL | IU/mL |
| Insulin concentration in nmol/L | Serum insulin concentration in nmol/L | nmol/L |
| Insulin concentration in nmol/L | Serum insulin concentration in nmol/L | nmol/L |
| Insulin concentration in pg/mL | Serum insulin concentration in pg/mL | pg/mL |
| Insulin concentration in pg/mL | Serum Insulin concentration in pg/mL | pg/mL |
| Insulin concentration in IU/mL | Serum Insulin concentration in IU/mL | IU/mL |
| Insulin concentration in IU/mL | Serum Insulin concentration in IU/mL | IU/mL |
| Insulin concentration in nmol/L | Serum Insulin concentration in nmol/L | nmol/L |
| Insulin concentration in nmol/L | Serum Insulin concentration in nmol/L | nmol/L |
| Insulin concentration in pg/mL | Serum Insulin concentration in pg/mL | pg/mL |
| Insulin concentration in pg/mL | Serum Insulin concentration in pg/mL | pg/mL |
| Parameter | Description |
| Age (years) | The mean age in years |
| Weight (kg) | The mean weight in kg |
| Height (cm) | The mean height in cm |
| Weighted average body mass (kg) | The mean body mass in kg |
| BMI (kg/m2) | The mean BMI in kg/m2 |
| Waist circumference (cm) | The mean waist circumference in cm |
| Systolic blood pressure (mmHg) | The mean systolic blood pressure in mmHg |
| Diastolic blood pressure (mmHg) | The mean diastolic blood pressure in mmHg |
| Heart rate (bpm) | The mean heart rate in beats per minute |
| Heart rate (beats/min) | The mean heart rate in beats/min |
| Systolic BP (mmHg) | The mean systolic BP in mmHg |
| Diastolic BP (mmHg) | The mean diastolic BP in mmHg |
| Heart rate (beats/min) | The mean heart rate in beats/min |
| Systolic BP (mmHg) | The mean systolic BP in mmHg |
| Diastolic BP (mmHg) | The mean diastolic BP in mmHg |
| Heart rate (beats/min) | The mean heart rate in beats/min |
| Systolic BP (mmHg) | The mean systolic BP |
| Diastolic BP (mmHg) | The mean diastolic BP |
| Variable | Description |
| Covariates: Age, sex, income, education, marital status, and type of insurance | 1. Cigarettes smoking, Poor houses, Poor housing, Poor health, Poor access to water, poor sanitation, poor food security, poor nutrition |
| Covariates: Gender, age, race, ethnicity, marital status, and type of insurance | 2. Gender, age, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 3. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 4. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 5. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 6. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 7. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 8. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 9. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 10. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 11. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 12. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 13. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 14. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 15. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 16. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 17. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 18. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 19. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 20. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 21. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 22. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 23. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 24. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 25. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 26. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 27. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 28. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 29. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 30. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 31. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 32. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 33. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 34. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 35. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 36. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 37. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 38. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 39. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 40. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 41. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 42. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 43. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 44. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 45. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 46. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 47. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 48. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 49. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 50. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 51. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 52. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 53. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 54. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 55. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 56. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 57. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 58. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 59. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 60. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 61. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 62. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 63. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 64. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 65. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 66. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 67. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 68. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 69. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 70. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 71. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 72. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 73. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 74. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 75. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 76. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 77. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 78. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 79. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 80. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 81. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 82. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 83. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 84. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 85. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 86. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 87. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 88. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 89. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 90. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 91. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 92. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 93. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 94. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 95. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 96. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 97. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 98. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 99. Age, gender, race, ethnicity, marital status, and type of insurance |
| Covariates: Age, gender, race, ethnicity, marital status, and type of insurance | 100. Age, gender, race, ethnicity, marital status |
Olympus
EUROPEAN AND WORLDWIDE WARFAE 1985-2004
| 1 | 100% (100%) |
| 2 | 100% (100%) |
| 3 | 100% (100%) |
| 4 | 100% (100%) |
| 5 | 100% (100%) |
| 6 | 100% (100%) |
| 7 | 100% (100%) |
| 8 | 100% (100%) |
| 9 | 100% (100%) |
| 10 | 100% (100%) |
| 11 | 100% (100%) |
| 12 | 100% (100%) |
| 13 | 100% (100%) |
| 14 | 100% (100%) |
| 15 | 100% (100%) |
| 16 | 100% (100%) |
| 17 | 100% (100%) |
| 18 | 100% (100%) |
| 19 | 100% (100%) |
| 20 | 100% (100%) |
| 21 | 100% (100%) |
| 22 | 100% (100%) |
| 23 | 100% (100%) |
| 24 | 100% (100%) |
| 25 | 100% (100%) |
| 26 | 100% (100%) |
| 27 | 100% (100%) |
| 28 | 100% (100%) |
| 29 | 100% (100%) |
| 30 | 100% (100%) |
| 31 | 100% (100%) |
| 32 | 100% (100%) |
| 33 | 100% (100%) |
| 34 | 100% (100%) |
| 35 | 100% (100%) |
| 36 | 100% (100%) |
| 37 | 100% (100%) |
| 38 | 100% (100%) |
| 39 | 100% (100%) |
| 40 | 100% (100%) |
| 41 | 100% (100%) |
| 42 | 100% (100%) |
| 43 | 100% (100%) |
| 44 | 100% (100%) |
| 45 | 100% (100%) |
| Before starting regarding the implementation of the project, please review the following information: | |||||
| 1. What is the purpose of the project? | Describe how the project was implemented to achieve its goals. | 2. What is the main purpose of the project? | 3. What is the main purpose of the project? | 4. What is the main purpose of the project? | 5. What is the main purpose of the project? |
| 1. What is the purpose of the project? | Describe how the project was implemented to achieve its goals. | 2. What is the main purpose of the project? | 3. What is the main purpose of the project? | 4. What is the main purpose of the project? | 5. What is the main purpose of the project? |
| 1. What is the purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 2. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 3. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 4. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 5. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 6. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 7. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 8. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 9. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 10. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 11. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 12. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 13. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 14. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 15. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 16. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 17. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 18. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 19. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 20. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 21. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 22. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 23. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 24. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 25. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 26. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 27. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 28. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 29. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 30. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 31. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 32. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 33. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 34. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 35. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 36. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 37. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 38. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 39. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 40. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 41. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 42. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 43. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 44. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 45. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 46. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 47. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 48. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 49. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 50. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 51. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 52. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 53. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 54. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 55. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 56. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 57. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 58. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 59. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 60. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 61. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 62. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 63. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 64. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 65. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 66. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 67. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 68. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 69. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 70. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 71. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 72. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 73. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 74. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 75. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 76. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 77. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 78. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 79. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 80. What is the main purpose of the project? | Describe how the project was implemented to achieve its goals. | ||||
| 1. | The use of a computer or device for the purpose of completing the questionnaire is acceptable. |
| 2. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 3. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 4. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 5. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 6. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 7. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 8. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 9. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 10. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 11. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 12. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 13. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 14. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 15. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 16. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 17. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 18. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 19. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 20. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 21. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 22. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 23. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 24. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 25. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 26. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 27. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 28. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 29. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 30. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 31. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 32. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 33. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 34. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 35. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 36. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 37. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 38. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 39. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 40. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 41. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 42. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 43. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 44. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 45. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 46. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 47. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 48. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 49. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 50. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 51. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 52. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 53. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 54. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 55. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 56. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 57. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 58. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 59. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 60. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 61. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 62. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 63. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 64. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 65. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 66. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 67. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 68. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 69. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 70. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 71. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 72. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 73. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 74. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 75. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 76. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 77. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 78. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 79. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 80. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 81. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 82. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 83. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 84. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 85. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 86. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 87. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 88. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 89. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 90. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 91. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 92. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 93. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 94. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 95. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 96. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 97. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 98. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 99. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| 100. | The use of a computer or device for the purpose of completing the questionnaire is not acceptable. |
| Experiments (1) | Experimental conditions (2) | Results and discussion |
| 1. Experiment 1: the effect of drug treatment on the expression of various genes in the brain. | (1) The expression of various genes was significantly increased in the hippocampus, thalamus, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 3) compared with vehicle (n= 4). (2) In the hippocampus, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (4) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (5) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n=4). (4) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). |
| 2. Experiment 2: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle ( n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle(n= 4). |
| 3. Experiment 3: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle(n= 4) compared with vehicle(n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats following intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes were significantly increased in the cerebellum, cerebellum, and cerebellum of rats following intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats following intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). |
| 4. Experiment 4: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle( n= 4 ) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebral white matter (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, or cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats following intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). |
| 5. Experiment 5: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). |
| 6. Experiment 6: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle. | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 μg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 μg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). |
| 7. Experiment 7: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle | |
| 8. Experiment 8: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle, compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus,the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle, compared with vehicle (n= 4). |
| 9. Experiment 9: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle,n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebella, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamic region, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day, compared with vehicle (n= 4). |
| 10. Experiment 10: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle,(n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In this study, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day (n= 4) compared with vehicle (n= 4). |
| 11. Experiment 11: the expression of various genes in the brain is significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle; (2) In the thalamus, the expression of various genes was significantly increased in the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal Administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). | (1) The expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (2) In the thalamus, the expression of various genes was significantly increased in these areas of the cerebellum, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicle (n= 4). (3) In the cerebellum, the expression of various genes was significantly increased in the thalamus, cerebellum, and cerebellum of rats after intranasal administration of 20 mg/kg/day of vehicle (n= 4) compared with vehicles (n= 4). |
| Treatment Group (n = 20) |
| 1. Treatment Group A: No treatment |
| 2. Treatment Group B: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 3. Treatment Group C: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 4. Treatment Group D: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 5. Treatment Group E: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 6. Treatment Group F: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 7. Treatment Group G: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 8. Treatment Group H: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 9. Treatment Group I: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 10. Treatment Group J: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 11. Treatment Group K: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 12. Treatment Group L: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 13. Treatment Group M: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 14. Treatment Group N: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 15. Treatment Group O: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 16. Treatment Group P: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 17. Treatment Group Q: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 18. Treatment Group R: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 19. Treatment Group S: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 20. Treatment Group T: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 21. Treatment Group U: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 22. Treatment Group V: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 23. Treatment Group VI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 24. Treatment Group VII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 25. Treatment Group VIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 26. Treatment Group IX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 27. Treatment Group X: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 28. Treatment Group XI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 29. Treatment Group XII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 30. Treatment Group XIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 31. Treatment Group XV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 32. Treatment Group XVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 33. Treatment Group XVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 34. Treatment Group XVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 35. Treatment Group XIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 36. Treatment Group XX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 37. Treatment Group XXI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 38. Treatment Group XXII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 39. Treatment Group XXIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 40. Treatment Group XXIV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 41. Treatment Group XXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 42. Treatment Group XXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 43. Treatment Group XXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 44. Treatment Group XXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 45. Treatment Group XXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 46. Treatment Group XXX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 47. Treatment Group XXXI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 48. Treatment Group XXXII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 49. Treatment Group XXXIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 50. Treatment Group XXXIV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 51. Treatment Group XXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 52. Treatment Group XXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 53. Treatment Group XXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 54. Treatment Group XXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 55. Treatment Group XXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 56. Treatment Group XXX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 57. Treatment Group XXXII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 58. Treatment Group XXXIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 59. Treatment Group XXXIV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 60. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 61. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 62. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 63. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 64. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 65. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 66. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 67. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 68. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 69. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 70. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 71. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 72. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 73. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 74. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 75. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 76. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 77. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 78. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 79. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 80. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 81. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 82. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 83. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 84. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 85. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 86. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 87. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 88. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 89. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 90. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 91. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 92. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 93. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 94. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 95. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 96. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 97. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 98. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 99. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 100. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 101. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 102. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 103. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 104. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 105. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 106. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 107. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 108. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 109. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 110. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 111. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 112. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 113. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 114. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 115. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 116. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 117. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 118. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 119. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 120. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 121. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 122. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 123. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 124. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 125. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 126. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 127. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 128. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 129. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 130. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 131. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 132. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 133. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 134. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 135. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 136. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 137. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 138. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 139. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 140. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 141. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 142. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 143. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 144. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 145. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 146. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 147. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 148. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 149. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 150. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 151. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 152. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 153. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 154. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 155. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 156. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 157. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 158. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 159. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 160. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 161. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 162. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 163. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 164. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 165. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 166. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 167. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 168. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 169. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 170. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 171. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 172. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 173. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 174. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 175. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 176. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 177. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 178. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 179. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 180. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 181. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 182. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 183. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 184. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 185. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 186. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 187. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 188. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 189. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 190. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 191. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 192. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 193. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 194. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 195. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 196. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 197. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 198. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 199. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 200. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 201. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 202. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 203. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 204. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 205. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 206. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 207. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 208. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 209. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 210. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 211. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 212. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 213. Treatment Group XXXV: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 214. Treatment Group XXXVI: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 215. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 216. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 217. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 218. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 219. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 220. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 221. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 222. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 223. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 224. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 225. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 226. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 227. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 228. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 229. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 230. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 231. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 232. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 233. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 234. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 235. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 236. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 237. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 238. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 239. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 240. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 241. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 242. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 243. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 244. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 245. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 246. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 247. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 248. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 249. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 250. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 251. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 252. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 253. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 254. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 255. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 256. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 257. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 258. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 259. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 260. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 261. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 262. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 263. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 264. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 265. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 266. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 267. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 268. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 269. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 270. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 271. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 272. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 273. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 274. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 275. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 276. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 277. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 278. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 279. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 280. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 281. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 282. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 283. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 284. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 285. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 286. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 287. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 288. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 289. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 290. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 291. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 292. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 293. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 294. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 295. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 296. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 297. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 298. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 299. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 300. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 301. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 302. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 303. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 304. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 305. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 306. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 307. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 308. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 309. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 310. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 311. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 312. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 313. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 314. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 315. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 316. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 317. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 318. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 319. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 320. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 321. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 322. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 323. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 324. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 325. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 326. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 327. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 328. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 329. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 330. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 331. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 332. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 333. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 334. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 335. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 336. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 337. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 338. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 339. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 340. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 341. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 342. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 343. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 344. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 345. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 346. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 347. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 348. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 349. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 350. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 351. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 352. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 353. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 354. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 355. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 356. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 357. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 358. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 359. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 360. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 361. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 362. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 363. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 364. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 365. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 366. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 367. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 368. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 369. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 370. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 371. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 372. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 373. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 374. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 375. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 376. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 377. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 378. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 379. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 380. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 381. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 382. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 383. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 384. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 385. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 386. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 387. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 388. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 389. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 390. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 391. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 392. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 393. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 394. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 395. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 396. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 397. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 398. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 399. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 400. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 401. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 402. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 403. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 404. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 405. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 406. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 407. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 408. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 409. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 410. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 411. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 412. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 413. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 414. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 415. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 416. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 417. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 418. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 419. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 420. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 421. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 422. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 423. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 424. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 425. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 426. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 427. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 428. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 429. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 430. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 431. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 432. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 433. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 434. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 435. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 436. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 437. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 438. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 439. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 440. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 441. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 442. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 443. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 444. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 445. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 446. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 447. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 448. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 449. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 450. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 451. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 452. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 453. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 454. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 455. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 456. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 457. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 458. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 459. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 460. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 461. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 462. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 463. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 464. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 465. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 466. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 467. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 468. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 469. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 470. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 471. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 472. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 473. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 474. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 475. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 476. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 477. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 478. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 479. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 480. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 481. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 482. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 483. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 484. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 485. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 486. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 487. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 488. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 489. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 490. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 491. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 492. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 493. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 494. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 495. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 496. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 497. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 498. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 499. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 500. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 501. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 502. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 503. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 504. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 505. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 506. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 507. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 508. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 509. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 510. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 511. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 512. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 513. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 514. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 515. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 516. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 517. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 518. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 519. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 520. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 521. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 522. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 523. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 524. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 525. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 526. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 527. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 528. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 529. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 530. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 531. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 532. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 533. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 534. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 535. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 536. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 537. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 538. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 539. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 540. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 541. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 542. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 543. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 544. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 545. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 546. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 547. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 548. Treatment Group XXXVII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 549. Treatment Group XXXVIII: Treatment with a combination of ACT, MMF, and/or MMF alone |
| 550. Treatment Group XXXIX: Treatment with a combination of ACT, MMF, and/or MMF alone |
| Management contract or compensatory plan | ||
| Management contract or compensatory plan | Management contract, compensatory plan, management contract, compensatory plan, management contract, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plans, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory program, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan, compensation plan | Management contract, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatory plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatorial plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan, compensatoria- tory plan |
| Question 1: A different point: |
| Question 2: A different point: |
| Question 3: A different point: |
| Question 4: A different point: |
| Question 5: A different point: |
| Question 6: A different point: |
| Question 7: A different point: |
| Question 8: A different point: |
| Question 9: A different point: |
| Question 10: A different point: |
| Question 11: A different point: |
| Question 12: A different point: |
| Question 13: A different point: |
| Question 14: A different point: |
| Question 15: A different point: |
| Question 16: A different point: |
| Question 17: A different point: |
| Question 18: A different point: |
| Question 19: A different point: |
| Question 20: A different point: |
| Question 21: A different point: |
| Question 22: A different point: |
| Question 23: A different point: |
| Question 24: A different point: |
| Question 25: A different point: |
| Question 26: A different point: |
| Question 27: A different point: |
| Question 28: A different point: |
| Question 29: A different point: |
| Question 30: A different point: |
| Question 31: A different point: |
| Question 32: A different point: |
| Question 33: A different point: |
| Question 34: A different point: |
| Question 35: A different point: |
| Question 36: A different point: |
| Question 37: A different point: |
| Question 38: A different point: |
| Question 39: A different point: |
| Question 40: A different point: |
| Question 41: A different point: |
| Question 42: A different point: |
| Question 43: A different point: |
| Question 44: A different point: |
| Question 45: A different point: |
| Question 46: A different point: |
| Question 47: A different point: |
| Question 48: A different point: |
| Question 49: A different point: |
| Question 50: A different point: |
| Question 51: A different point: |
| Question 52: A different point: |
| Question 53: A different point: |
| Question 54: A different point: |
| Question 55: A different point: |
| Question 56: A different point: |
| Question 57: A different point: |
| Question 58: A different point: |
| Question 59: A different point: |
| Question 60: A different point: |
| Question 61: A different point: |
| Question 62: A different point: |
| Question 63: A different point: |
| Question 64: A different point: |
| Question 65: A different point: |
| Question 66: A different point: |
| Question 67: A different point: |
| Question 68: A different point: |
| Question 69: A different point: |
| Question 70: A different point: |
| Question 71: A different point: |
| Question 72: A different point: |
| Question 73: A different point: |
| Question 74: A different point: |
| Question 75: A different point: |
| Question 76: A different point: |
| Question 77: A different point: |
| Question 78: A different point: |
| Question 79: A different point: |
| Question 80: A different point: |
| Question 81: A different point: |
| Question 82: A different point: |
| Question 83: A different point: |
| Question 84: A different point: |
| Question 85: A different point: |
| Question 86: A different point: |
| Question 87: A different point: |
| Question 88: A different point: |
| Question 89: A different point: |
| Question 90: A different point: |
| Question 91: A different point: |
| Question 92: A different point: |
| Question 93: A different point: |
| Question 94: A different point: |
| Question 95: A different point: |
| Question 96: A different point: |
| Question 97: A different point: |
| Question 98: A different point: |
| Question 99: A different point: |
| Question 100: A different point: |
| Item | Description |
| 1. | The number of medications taken per day, including the number of times taken each day, and the amount taken per day. |
| 2. | The number of medications taken per week, including the number of times taken each week, and the amount taken per week. |
| 3. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 4. | The number of medications taken per year, including the number of times taken each year, and the amount taken per year. |
| 5. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 6. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 7. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 8. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 9. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 10. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 11. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 12. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 13. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 14. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 15. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 16. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 17. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 18. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 19. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 20. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 21. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 22. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 23. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 24. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 25. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 26. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| 27. | The number of medications taken per month, including the number of times taken each month, and the amount taken per month. |
| OLOPMUS European AND WORLD-WIDE WARRANTY 20 YEARS EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20 YEARS EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20 YEARS EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20Years EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20Years EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20Years EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20Years EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 20Years EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1985 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1984 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1983 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1982 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1981 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1980 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1895 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1894 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1893 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1892 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1887 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1886 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1885 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1884 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1883 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1882 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1881 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1877 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1876 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1875 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1874 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1873 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1872 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1867 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1866 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1865 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1864 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1863 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1862 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1861 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1857 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1856 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1855 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1854 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1853 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1852 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1851 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1847 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1846 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1845 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1844 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1843 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1842 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1841 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1840 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1837 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1836 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1835 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1834 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1833 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1832 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1831 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1830 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1829 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1828 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1827 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1826 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1825 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1824 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1823 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1822 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1821 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1820 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1797 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1796 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1795 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1794 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1793 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1792 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1791 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1790 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1697 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1696 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1695 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1694 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1693 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1692 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1691 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1690 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1597 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1596 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1595 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1594 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1593 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1592 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1591 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1590 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1497 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1496 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1495 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1494 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1493 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1492 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1491 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1490 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1397 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1396 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1395 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1394 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1393 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1392 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1391 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1390 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1297 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1296 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1295 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1294 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1293 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1292 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1291 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1290 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1289 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1288 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1287 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1286 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1285 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1284 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1283 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1282 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1281 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1280 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1277 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1276 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1275 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1274 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1273 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1272 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1271 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1269 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1268 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1267 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1266 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1265 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1264 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1263 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1262 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1261 EUROPEAN WARRANTY | ||||||||||||||||||||
| OLOPMUS European AND WORLD-WIDE WARRANTY 1260 EUROPEAN WARRANTY. | 1985 EUROPEAN OLOPMUS HONORIUM OLOPMUS HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONORIUM HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOUR S HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURRSE HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURB HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURs HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURPES HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURIS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURC HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURRS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOUR R HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURRs HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURrs HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURrS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOUR#S HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONoura# HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS | 1985 EUROPEAN OLOPMUS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOUR##S HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HON OURAS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOUR# HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S | 1985 EUROPEAN OLOPMUS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS | 1985 EUROPEAN OLOPMUS TROUBLESHOOTING HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOURS HONOUR###S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S HONOURR#S | ||||||||||||||||